Summary of the clinical studies reported in the Scientific Session of the American Heart Association 2005 (Dallas, Texas, USA, 13-16 November 2005)

被引：30

作者：

Bermejo, J ^{[1
]}

Segovia, J ^{[1
]}

Alfonso, F ^{[1
]}

机构：

[1] Sociedad Espalona Cardiol, Madrid 28028, Spain

来源：

REVISTA ESPANOLA DE CARDIOLOGIA | 2006年 / 59卷 / 02期

关键词：

D O I：

10.1016/S1885-5857(06)60123-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：143 / 153

页数：11

共 7 条

[1]

Alexander JH, 2005, JAMA-J AM MED ASSOC, V294, P2446

[2] Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids - Results of the OmniHeart randomized trial [J].

Appel, LJ ;

Sacks, FM ;

Carey, VJ ;

Obarzanek, E ;

Swain, JF ;

Miller, ER ;

Conlin, PR ;

Erlinger, TP ;

Rosner, BA ;

Laranjo, NM ;

Charleston, J ;

McCarron, P ;

Bishop, LM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (19) :2455-2464

[3] Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial [J].

Dormandy, JA ;

Charbonnel, B ;

Eckland, DJA ;

Erdmann, E ;

Massi-Benedetti, M ;

Kmoules, IK ;

Skene, AM ;

Tan, MH ;

Lefébvre, PJ ;

Murray, GD ;

Standl, E ;

Wilcox, RG ;

Wlhelmsen, L ;

Betteridge, J ;

Birkeland, K ;

Golay, A ;

Heine, RJ ;

Korányi, L ;

Laakso, M ;

Mokán, M ;

Norkus, A ;

Pirags, V ;

Podar, T ;

Scheen, A ;

Scherbaum, W ;

Schernthaner, G ;

Schmitz, O ;

Skrha, J ;

Smith, U ;

Taton, J .

LANCET, 2005, 366 (9493) :1279-1289

[4] Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study):: randomised controlled trial [J].

Keech, A ;

Simes, RJ ;

Barter, P ;

Best, J ;

Scott, R ;

Taskinen, MR ;

Forder, P ;

Pillai, A ;

Davis, T ;

Glasziou, P ;

Drury, P ;

Kesäniemi, YA ;

Sullivan, D ;

Hunt, D ;

Colman, P ;

d'Emden, M ;

Whiting, M ;

Ehnholm, C ;

Laakso, M .

LANCET, 2005, 366 (9500) :1849-1861

[5]

Nakamura H, 2004, CIRC J, V68, P860

[6] High-dose atorvastatin vs usual dose simvastatin for secondary prevention after myocardial infarction - The IDEAL study: A randomized controlled trial [J].

Pedersen, TR ;

Faergeman, O ;

Kastelein, JJP ;

Olsson, AG ;

Tikkanen, MJ ;

Holme, I ;

Larsen, ML ;

Bendiksen, FS ;

Lindahl, C ;

Szarek, M ;

Tsai, J .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (19) :2437-2445

[7] Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia: Rationale, design, and baseline characteristics of the Japan EPA Lipid Intervention Study (JELIS) [J].

Yokoyama, M ;

Origasa, H .

AMERICAN HEART JOURNAL, 2003, 146 (04) :613-620

← 1 →